David McClung - Apr 14, 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
Chief Financial Officer
Signature
/s/ David McClung
Stock symbol
BCDA
Transactions as of
Apr 14, 2022
Transactions value $
$0
Form type
4
Date filed
4/18/2022, 09:17 PM
Previous filing
Jun 11, 2021
Next filing
Apr 7, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Award $0 +50.3K +107.56% $0.00 97.2K Apr 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Stock Option (right to buy) Award $0 +60K $0.00 60K Apr 14, 2022 Common Stock 60K $1.49 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022.
F2 The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.